Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Lung inflammatory injury and tissue repair (Jul 2023)
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
mRNA deadenylation and telomere disease
Philip J. Mason, Monica Bessler
Philip J. Mason, Monica Bessler
Published April 20, 2015
Citation Information: J Clin Invest. 2015;125(5):1796-1798. https://doi.org/10.1172/JCI81506.
View: Text | PDF | Corrigendum
Commentary

mRNA deadenylation and telomere disease

  • Text
  • PDF
Abstract

Dyskeratosis congenita (DC) is an inherited BM failure disorder that is associated with mutations in genes involved with telomere function and maintenance; however, the genetic cause of many instances of DC remains uncharacterized. In this issue of the JCI, Tummala and colleagues identify mutations in the gene encoding the poly(A)-specific ribonuclease (PARN) in individuals with a severe form of DC in three different families. PARN deficiency resulted in decreased expression of genes required for telomere maintenance and an aberrant DNA damage response, including increased levels of p53. Together, the results of this study support PARN as a DC-associated gene and suggest a potential link between p53 and telomere shortening.

Authors

Philip J. Mason, Monica Bessler

×

Figure 1

Possible effects of PARN depletion on telomeres.

Options: View larger image (or click on image) Download as PowerPoint
Possible effects of PARN depletion on telomeres.
(A) DNA damage in repli...
(A) DNA damage in replicating WT cells causes increased levels of the tumor suppressor p53, which in turn induces p21 and the DNA damage response. p53 also activates the PARN deadenylase, which destabilizes p53 mRNA, thereby reducing p53 levels (17). (B) In the absence of PARN, p53 levels can increase unchecked and lead to inhibition of telomere-related genes and short telomeres. Shortened telomeres exacerbate the DNA damage response, further increasing p53 levels, and thereby activating a cycle that leads to short telomeres and cell cycle arrest in rapidly replicating cells — a hallmark of DC pathobiology.

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts